Marshall Wace’s New Frontier Health Corporation Ordinary Shares NFH Stock Holding History

Marshall Wace’s Portfolio NFH Stock Details NFH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-199,980	Closed	-$2.29M	–	4384
2021 Q4	$2.29M	Buy	+199,980	New	+$2.25M	﹤0.01%	1956
2021 Q2	–	Sell	-11,162	Closed	-$126K	–	3426
2021 Q1	$126K	Sell	11,162 -3,418	-23%	-$34.7K	﹤0.01%	2336
2020 Q4	$126K	Buy	+14,580	New	+$126K	﹤0.01%	1788
2019 Q4	–	Sell	-243,620	Closed	-$2.48M	–	2203
2019 Q3	$2.48M	Hold	243,620	–	–	0.02%	703
2019 Q2	$2.45M	Buy	+243,620	New	+$2.44M	0.02%	715

Other funds holding NFH

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Marshall Wace's NFH Position: Q1 2022 in Review

Marshall Wace sold out of New Frontier Health Corporation Ordinary Shares (NFH) in Q1 2022, closing a stake of 199,980 shares — an estimated $2.29M sold.

Marshall Wace first reported a position in NFH in Q2 2019 and held it in 5 quarters. The position peaked at $2.48M in Q3 2019. 2 funds tracked by Wall St. Rank hold NFH as of Q1 2022.

Marshall Wace reported no remaining New Frontier Health Corporation Ordinary Shares position as of Q1 2022 after selling out during the quarter.
Marshall Wace sold 199,980 New Frontier Health Corporation Ordinary Shares shares in Q1 2022, an estimated $2.29M.
Marshall Wace first reported a position in New Frontier Health Corporation Ordinary Shares in Q2 2019 and held it in 5 quarters.
Marshall Wace's New Frontier Health Corporation Ordinary Shares position peaked at $2.48M in Q3 2019.
2 funds tracked by Wall St. Rank held New Frontier Health Corporation Ordinary Shares as of Q1 2022.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.